Zobrazeno 1 - 10
of 22
pro vyhledávání: '"May A Shawki"'
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Denosumab and alendronate had a positive impact on bone mineral density (BMD) preservation after kidney transplantation. However, the cost-effectiveness of these agents in the context of kidney transplantation remains largely unex
Externí odkaz:
https://doaj.org/article/de96ba0965e4443289d543b6a7c00baa
Autor:
May Ahmed Shawki, Nagwa Ali Sabri, Dina Mohamed Ibrahim, Mohamed Maged Samady, Marwa Samir Hamza
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 8, Pp 1101-1106 (2022)
Background: Clinical pharmacists have a vital role during COVID-19 pandemic in mitigating medication errors, particularly prescribing errors in hospitals. That is owing to the fact that prescribing errors during the COVID-19 pandemic has increased. A
Externí odkaz:
https://doaj.org/article/f3c49734f46b4f9a995855219c96b651
Autor:
Ahmed H. Abdelaziz, May A. Shawki, Amrou M. Shaaban, Sali K. Albarouki, Ahmad M. Rachid, Obai M. Alsalhani, Mona K. Jomaa
Publikováno v:
Research in Oncology, Vol 17, Iss 1, Pp 1-8 (2021)
Background: Breast cancer is the most common cancer in Egyptian females. Most patients present at a late stage with subsequent poor outcomes. Aim: To study the awareness of breast cancer, its risk factors and screening. To investigate the impact of
Externí odkaz:
https://doaj.org/article/ec069741ec6940009741cc55a4bb5a4e
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Albumin is an expensive non-blood plasma substitutes with limited availability that has been reported to be inappropriately used in healthcare settings. Hence, interventions are recommended to control its misuse.Objective: To evaluate t
Externí odkaz:
https://doaj.org/article/b0da12f11a1243b3a4f8b1dbf5f0d172
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in animal models. Objectives: The objective was to investigate the efficacy and safety of nicotinamide
Externí odkaz:
https://doaj.org/article/7955900d98cf47d8a7771f22fcbde489
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: To evaluate the efficacy and safety of metformin use in rheumatoid arthritis (RA) patients receiving conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs).Methods: A prospective, randomized, controlled, single blinded, s
Externí odkaz:
https://doaj.org/article/5e3a2c3b38b44db9900227300e9fbb85
Autor:
Sarah Nabil, Nagla A. El-Shitany, May Ahmed Shawki, Mahmoud Mahmoud Abbas Ellithy, Raafat Abdelfattah, Mahmoud Salah, Samir Eid, Manal Hamed El-Hamamsy
Publikováno v:
The Egyptian Journal of Hospital Medicine. 89:4874-4880
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19fb4d921ad8922c81c7f6287551750b
https://doi.org/10.21608/ejhm.2022.260758
https://doi.org/10.21608/ejhm.2022.260758
Publikováno v:
The American Journal of the Medical Sciences. 362:143-153
The incidence of drug related problems (DRPs) in intensive care units (ICU) is higher compared to any other wards in the hospital, requiring a structured pathway to ensure optimum detection of DRPs. The study aimed to evaluate the impact of implement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc4925390e08db48daccb5881fb89ab
https://doi.org/10.1016/j.amjms.2021.03.007
https://doi.org/10.1016/j.amjms.2021.03.007
Autor:
Mona K. Jomaa, Amrou Shaaban, Obai M. Alsalhani, Ahmad Rachid, Sali K. Albarouki, May A. Shawki, Ahmed H. Abdelaziz
Publikováno v:
Research in Oncology, Vol 17, Iss 1, Pp 1-8 (2021)
Background: Breast cancer is the most common cancer in Egyptian females. Most patients present at a late stage with subsequent poor outcomes. Aim: To study the awareness of breast cancer, its risk factors and screening. To investigate the impact of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82d8f2d26dac9589b86d9f465e930a7f
https://resoncol.journals.ekb.eg/article_124868_da332d034a0db99729e35909e051a557.pdf
https://resoncol.journals.ekb.eg/article_124868_da332d034a0db99729e35909e051a557.pdf
Publikováno v:
Immunopharmacology and Immunotoxicology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
A global threat has emerged in 2019 due to the rapid spread of Coronavirus disease (COVID-19). As of January 2021, the number of cases worldwide reached 103 million cases and 2.22 million deaths which were confirmed as the severe acute respiratory sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a543022677a378aca299fb7bef53fc
https://doi.org/10.1080/08923973.2021.1931302
https://doi.org/10.1080/08923973.2021.1931302